289 related articles for article (PubMed ID: 23859435)
1. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury.
Grossman RG; Fehlings MG; Frankowski RF; Burau KD; Chow DS; Tator C; Teng A; Toups EG; Harrop JS; Aarabi B; Shaffrey CI; Johnson MM; Harkema SJ; Boakye M; Guest JD; Wilson JR
J Neurotrauma; 2014 Feb; 31(3):239-55. PubMed ID: 23859435
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of riluzole in acute spinal cord injury.
Chow DS; Teng Y; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Johnson MM; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):129-40. PubMed ID: 22985379
[TBL] [Abstract][Full Text] [Related]
3. Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial.
Chow DS; Nguyen A; Park J; Wu L; Toups EG; Harrop JS; Guest JD; Schmitt KM; Aarabi B; Fehlings MG; Boakye M; Grossman RG
J Neurotrauma; 2023 Sep; 40(17-18):1889-1906. PubMed ID: 37130044
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial.
Fehlings MG; Moghaddamjou A; Harrop JS; Stanford R; Ball J; Aarabi B; Freeman BJC; Arnold PM; Guest JD; Kurpad SN; Schuster JM; Nassr A; Schmitt KM; Wilson JR; Brodke DS; Ahmad FU; Yee A; Ray WZ; Brooks NP; Wilson J; Chow DS; Toups EG; Kopjar B
J Neurotrauma; 2023 Sep; 40(17-18):1878-1888. PubMed ID: 37279301
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature.
Srinivas S; Wali AR; Pham MH
Neurosurg Focus; 2019 Mar; 46(3):E6. PubMed ID: 30835675
[TBL] [Abstract][Full Text] [Related]
6. Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial.
Fehlings MG; Wilson JR; Frankowski RF; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Harkema SJ; Guest JD; Tator CH; Burau KD; Johnson MW; Grossman RG
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):151-6. PubMed ID: 22985381
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent.
Nguyen A; Chow DS; Wu L; Teng YA; Sarkar M; Toups EG; Harrop JS; Schmitt KM; Johnson MM; Guest JD; Aarabi B; Shaffrey CI; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
J Clin Pharmacol; 2021 Sep; 61(9):1232-1242. PubMed ID: 33908635
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Fehlings MG; Badhiwala JH; Ahn H; Farhadi HF; Shaffrey CI; Nassr A; Mummaneni P; Arnold PM; Jacobs WB; Riew KD; Kelly M; Brodke DS; Vaccaro AR; Hilibrand AS; Wilson J; Harrop JS; Yoon ST; Kim KD; Fourney DR; Santaguida C; Massicotte EM; Kopjar B
Lancet Neurol; 2021 Feb; 20(2):98-106. PubMed ID: 33357512
[TBL] [Abstract][Full Text] [Related]
9. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.
Fehlings MG; Nakashima H; Nagoshi N; Chow DS; Grossman RG; Kopjar B
Spinal Cord; 2016 Jan; 54(1):8-15. PubMed ID: 26099215
[TBL] [Abstract][Full Text] [Related]
10. Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection.
Satkunendrarajah K; Nassiri F; Karadimas SK; Lip A; Yao G; Fehlings MG
Exp Neurol; 2016 Feb; 276():59-71. PubMed ID: 26394202
[TBL] [Abstract][Full Text] [Related]
11. Natural history of neurological improvement following complete (AIS A) thoracic spinal cord injury across three registries to guide acute clinical trial design and interpretation.
Aimetti AA; Kirshblum S; Curt A; Mobley J; Grossman RG; Guest JD
Spinal Cord; 2019 Sep; 57(9):753-762. PubMed ID: 31182786
[TBL] [Abstract][Full Text] [Related]
12. North American Clinical Trials Network for the Treatment of Spinal Cord Injury: goals and progress.
Grossman RG; Toups EG; Frankowski RF; Burau KD; Howley S
J Neurosurg Spine; 2012 Sep; 17(1 Suppl):6-10. PubMed ID: 22985365
[TBL] [Abstract][Full Text] [Related]
13. An Introduction to the North American Clinical Trials Network for Spinal Cord Injury Special Edition: Reflections on Accomplishments and a Look to the Future.
Fehlings MG; Neal CJ; Hejrati N; Harrop JS; Toups EG; Guest JD
J Neurotrauma; 2023 Sep; 40(17-18):1811-1816. PubMed ID: 37668560
[TBL] [Abstract][Full Text] [Related]
14. Riluzole improves functional recovery after acute spinal cord injury in rats and may be associated with changes in spinal microglia/macrophages polarization.
Wu Q; Zhang Y; Zhang Y; Zhang W; Zhang W; Liu Y; Xu S; Guan Y; Chen X
Neurosci Lett; 2020 Apr; 723():134829. PubMed ID: 32057920
[TBL] [Abstract][Full Text] [Related]
15. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.
Nagoshi N; Nakashima H; Fehlings MG
Molecules; 2015 Apr; 20(5):7775-89. PubMed ID: 25939067
[TBL] [Abstract][Full Text] [Related]
16. Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats.
Martins BC; Torres BBJ; de Oliveira KM; Lavor MS; Osório CM; Fukushima FB; Rosado IR; de Melo EG
Spine J; 2018 Mar; 18(3):532-539. PubMed ID: 29155254
[TBL] [Abstract][Full Text] [Related]
17. Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury.
Wu Y; Satkunendrarajah K; Teng Y; Chow DS; Buttigieg J; Fehlings MG
J Neurotrauma; 2013 Mar; 30(6):441-52. PubMed ID: 23517137
[TBL] [Abstract][Full Text] [Related]
18. Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy.
Wilson JR; Fehlings MG
World Neurosurg; 2014; 81(5-6):825-9. PubMed ID: 23295632
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers.
Le Liboux A; Cachia JP; Kirkesseli S; Gautier JY; Guimart C; Montay G; Peeters PA; Groen E; Jonkman JH; Wemer J
J Clin Pharmacol; 1999 May; 39(5):480-6. PubMed ID: 10234595
[TBL] [Abstract][Full Text] [Related]
20. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
